Pfizer Inc. (LON:0Q1N)

Market Cap	117.90B
Revenue (ttm)	50.82B
Net Income (ttm)	6.41B
Shares Out	n/a
EPS (ttm)	1.13
PE Ratio	18.38
Forward PE	n/a
Dividend	1.33 (5.10%)
Ex-Dividend Date	Jan 24, 2025

Volume	66,775
Average Volume	130,050
Open	25.90
Previous Close	26.00
Day's Range	25.85 - 26.52
52-Week Range	19.48 - 25.24
Beta	0.57
RSI	52.17
Earnings Date	Feb 4, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and po...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 88,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q1N

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 8.77% compared to the previous year's $58.50 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD